Table 2. Baseline angiographic characteristics.
| Clopidogrel | Prasugrel/Ticagrelor | p | |
|---|---|---|---|
| (n = 448) | (n = 282) | ||
| Mono-vessel disease, n (%) | 170 (38) | 142 (50,5) | 0.001 |
| Dual-vessel disease, n (%) | 144 (32) | 91 (32,4) | 0.9 |
| Three-vessel disease, n (%) | 135 (30) | 48 (17,1) | 0.0001* |
| LAD, n (%) | 299 (66,7) | 173 (61,6) | 0.2 |
| CX, n (%) | 161 (36) | 85 (30,2) | 0.1 |
| RCA, n (%) | 265 (59,2) | 138 (49,1) | 0.009 |
| Left main coronary artery, n (%) | 26 (5,8) | 10 (3,6) | 0.2 |
| Bifurcation n (%) | 37 (8,2) | 5 (1,8) | 0.0001 |
| Total stent's length (mm) | 25.9 +/− 15.5 (12–122) | 29.9 +/− 21.7 (12–188) | 0.005 |
| Stent's diameter (mm) | 3.1 +/− 0.5 (2.5–4.5) | 3.0 +/− 0.5 (3–5) | 0.83 |
| DES | 236 (52.7) | 259 (92.5) | < 0.0001 |
Values are n +/− median (range) or n (%)
*
Variable used to create propensity score
LAD = left anterior descending artery; CX = circumflex artery; RCA = right coronary artery